The Board of Directors manages the business and property of the Society, proposes new members, and arranges the annual scientific meeting of the Society.
The CSN Board consists of:
The CSN Officers
Regional representation Directors from Western Canada, Ontario, Quebec and the Atlantic provinces
The President of the Canadian Association of Pediatric Nephrologists (CAPN)
Chairs of the various committees of the CSN
Dr. Rita
Suri
President
(2026 - 2028)
Dr. Rita Suri
President-Elect (2026 - 2028)
Dr. Suri is an Associate Professor and Director of the Division of Nephrology at McGill University, and holds the Catherine MacLaughlin Hakim Chair in Medicine for excellence in research. She is nationally recognized for leadership in hemodialysis research, network development, patient advocacy, and teaching. She has authored >100 publications, and participated on multiple national and international guideline panels. She currently serves as medical Chair of the Kidney Foundation of Canada Research Council, as an Executive Member of the Kidney Disease Improving Global Outcomes group, and is President-Elect of the Canadian Society of Nephrology. In 2025, she was awarded a King Charles III Coronation Medal for her accomplishments in nephrology and patient advocacy.
Dr. Lakshman
Gunaratnam
President-Elect
(2026 - 2028)
Dr. Lakshman Gunaratnam
President-Elect (2026 - 2028)
Dr. Gunaratnam is a Nephrologist and Professor of Medicine at Western University. He holds the Dr. Robert Zhang Chair in Translational Transplant Research at Western and is the Medical Director of the Multi-Organ Transplant Program at the London Health Sciences Center. He is a recognized basic and translational research scientist whose work is helping us to understand the mechanisms underlying acute kidney injury and develop therapeutic strategies to prolong the lifespan of kidney transplants and treat metastatic kidney cancer. He was an inaugural Fellow of the KRESCENT Program and has won many research and leadership awards, including the 2023 Canadian Society of Transplantation (CST) Research Excellence award and a KRESCENT New Investigator Award. Dr. Gunaratnam’s research program has been continuously supported by peer-reviewed funding from national agencies, including the Canadian Institutes for Health Research (CIHR), the Kidney Foundation of Canada (KFOC), the Natural Sciences and Engineering Research Council of Canada, the Government of Ontario, and the Canadian Foundation for Innovation. Dr. Gunaratnam has been recognized as a gifted teacher at Western University, where he has taught immunology at the undergraduate, graduate, graduate and medical curricula. He has held several leadership positions, including Canadian Blood Services, KFOC, Trillium Gift of Life Network, the CST, and the Canadian Institutes of Health Research. He is also the President of the Ontario Association of Nephrologists and Chair of the Ontario Medical Association’s Section on Nephrology. In 2025, he was awarded the CST Leadership Excellence Award in recognition of his outstanding leadership ability.
Dr. Tomoko
Takano
Past-President
(2026-2028)
Dr. Tomoko Takano
President (2026 - 2028)
Dr. Takano is a nephrologist at the McGill University Health Centre (MUHC), a Professor of Medicine at McGill University, and a Senior Scientist at the Research institute of the MUHC. Dr. Takano’s research focuses on the pathogenesis of proteinuria and nephrotic syndrome and her work in podocyte biology is internationally recognized. She is also active in-patient care and teaching at all levels. She served as the Chair of the CSN Scientific Committee (2016-2020) and the Local Organizing Working Group for the WCN 2021 (Montreal). She is also one of the founding members of the network of Canadian fundamental kidney researchers (CKD-N) and advocates the role of discovery research in nephrology.
Dr. Jay
Hingwala
Treasurer
(2024 – 2028)
Dr. Jay Hingwala
Treasurer (2026 – 2027)
Jay Hingwala is a Nephrologist and Associate Professor of Medicine at the University of Manitoba and serves as the Medical Director of the Home Hemodialysis and Transitional Dialysis Care at the Winnipeg Health Sciences Centre. He completed his clinical training in Internal Medicine at the University of Manitoba, followed by subspecialty training in Nephrology at the University of Toronto. He has also completed a Master of Science Degree in Quality Improvement and Patient Safety at the Institute of Health Policy, Management and Evaluation at the University of Toronto, where he now also holds a faculty cross appointment. His research interests focus on quality improvement interventions that improve care of patients that are transitioning onto chronic dialysis.
He grew up in the Winnipeg and has many strong roots to the prairie community. Through the years, he has gained extensive experience in working on committees and in previous elected council positions within the University, with key successes including initiatives to foster collaborations with stakeholders and industry, creating future visions and strategies, and improving the financial positions of the organizations. His nephrology quality improvement work includes innovative initiatives in transitional care for chronic dialysis, growing home dialysis, reducing medication administration errors in hemodialysis, , streamlining virtual ambulatory renal care, and establishing key performance indicators.. He also serves of the Canadian Nephrology Quality Improvement and Implementation Science Collaborative (CSN-QUIS).
Dr. William
Beaubien-Souligny
Director: Province of Québec
(2025 - 2028)
Dr. Beaubien-Souligny
Director, Québec (2025 - 2028)
Dr. William Beaubien-Souligny is an Associate Professor of Medicine at the Université de Montréal and a clinician-scientist at the Centre de recherche du CHUM. He specializes in nephrology and critical care, with a research focus on ultrasound applications, hemodynamic monitoring, and fluid management in acute kidney injury and dialysis. He has received research grants, including support from the FRQS and CIHR, and has authored over 90 peer-reviewed publications.
Dr. Mark
Courtney
Director: Western Provinces
(2024 - 2027)
Dr. Mark Courtney
Director, Western Provinces (2024 - 2027)
Dr. Mark Courtney graduated medical school University of Ottawa 1995 and completed internal medicine and nephrology training at the University of Alberta. Dr. Courtney has a Masters degree in patient safety from Imperial College London and is the program director for the nephrology residency training program at the University of Alberta. His research interest is in virtual care outcomes and improving access to nephrology consultation.
Dr. Varun
Dev
Chair: Community Nephrology Committee
(2024 - 2027)
Dr. Varun Dev
Chair, Community Nephrology Committee (2024 - 2027)
Dr. Varun Dev is a Staff Nephrologist and Medical Lead at Humber River Hospital in Toronto, Ontario. He completed his Masters in Health Administration at the University of Toronto and his interests include quality improvement and physician leadership. He is the Secretary and Treasurer of the Board of the Ontario Association of Nephrologists, and has been involved in creating and delivering leadership curriculums at the graduate, postgraduate and national level. He is also an active consultant, advisor, and investor in early-stage healthcare technology companies.
Dr. Ainslie
Eberhart
Chair: Education Committee
(2026 - 2029)
Dr. Ainslie Eberhart
Chair, Education Committee (2026 - 2029)
Dr. Eberhart completed her Nephrology Fellowship at Western University in 2012, followed by a Master of Sciences in Clinical Epidemiology and Biostatistics at Western University and additional training in Glomerulonephritis and Renal Diseases of Pregnancy at the University of Toronto. She is currently an Assistant Professor in the Division of Nephrology at the University of Alberta with a clinical and research focus on improving care and outcomes of patients with glomerular disease.
Dr. Rémi
Goupil
Director: Province of Quebec
(2024 - 2027)
Dr. Rémi Goupil
Director: Province of Quebec (2024 - 2027)
Dr. Rémi Goupil is a nephrologist at the Hôpital du Sacré-Coeur de Montréal and an associate clinical professor at the Université de Montréal. He is a FRQS Junior 2 clinician-scientist focusing on optimising blood pressure measurements and hypertension management. His research program is funded by the Canadian Institutes of Health Research, the Kidney Foundation, the Heart + Stroke Foundation and the Société québécoise d'hypertension artérielle. For his achievements, he has received several awards, such as the Young Nephrologist Award from the Société québécoise de Néphrologie (2022) and New Investigator awards from the Canadian Society of Nephrology (2020) and the Société québécoise d'hypertension artérielle (2022).
Dr. Tyrone
Harrison
Chair: CPG Committee
(2024 - 2027)
Dr. Tyrone Harrison
Chair, Clinical Practice Guidelines Committee (2024 - 2027)
Dr Tyrone Harrison MD PhD is an assistant professor of Medicine at the University of Calgary, where he works as a health services researcher and nephrologist. His current research program is mainly focused on integrating person-centredness within risk prediction strategies and population-based cohort studies for people with chronic diseases. His work is funded by the Kidney Foundation of Canada, and he is currently supported by a KRESCENT New Investigator Award (2023-2026). He is the current Chair of the CSN clinical practice guidelines committee. As part of the guidelines committee work, he has interest in incorporating the perspectives of people with lived experience and other stakeholders in determining committee priorities.
Dr. Fareed
Kamar
Director: Western Provinces
(2025 - 2028)
Dr. Fareed Kamar
Director: Western Provinces (2025-2028)
Dr. Fareed Kamar completed medical school in Calgary, where he then underwent specialization in internal medicine, nephrology, and transplant medicine. He practices general and transplant nephrology out of Calgary’s four hospitals and is the medical lead for inpatient nephrology at the Foothills Medical Center.
Dr. Mathieu
Lemaire
President: CAPN
(2025 - 2027)
Dr. Mathieu Lemaire
President, Canadian Association Of Pediatric Nephrologists (2025 - 2027)
After finishing his medical training at McGill University, Dr. Lemaire moved to Toronto to learn Paediatrics and Nephrology at SickKids before moving to Yale University to pursue a Ph.D. under the guidance of Dr. Richard Lifton. There, he focused on gene discovery studies for rare pediatric kidney diseases. This work led to the discovery of two novel forms of atypical hemolytic-uremic syndrome. He then returned to SickKids, joining the Division of Nephrology, the Cell Biology program at the SickKids Research Institute, and the Department of Biochemistry at the University of Toronto. Dr. Lemaire was part of the KRESCENT program as a research fellow and early-career investigator; he recently became the Director of KRESCENT. Much of his work in the lab and clinic focuses on rare genetic diseases affecting the kidneys of children, including glomerular, cystic, metabolic and tubular conditions.
Dr. Anna
Mathew
Director: Province of Ontario
(2026 - 2029)
Dr. Anna Mathew
Director, Province of Ontario (2026 - 2029)
Tamara Glavinovic is a Nephrologist at the University of Ottawa and has a clinical focus in reproductive health in kidney disease and quality improvement. Having grown up in Montreal, she completed her medical degree at McGill University followed by Internal Medicine training at the University of Manitoba and Nephrology at the University of Toronto. She then completed a fellowship in glomerulonephritis at Monash Health Centre, Melbourne, Australia, along with advanced training in pregnancy and kidney disease at Sunnybrook Health Sciences Center. She completed a Master’s in Public Health with a focus on quality improvement as well as a Master’s in Clinical Education through the University of Melbourne.
Dr. Danielle
Moorman
Director: Province of Ontario
(2024 – 2027)
Dr. Danielle Moorman
Director: Province of Ontario (2024 – 2027)
Dr Danielle Moorman is a community nephrologist in Ottawa providing outpatient care across the region and inpatient care at the Queensway Carleton Hospital. Prior to attending medical school in Ireland she completed a Master’s in Cellular and Molecular Medicine examining a mouse model of CKD. She returned to Ottawa for her Internal Medicine training and attended Queen’s University for her Nephrology training. She completed an additional fellowship in Advanced Chronic Kidney Disease and Conservative Kidney Care at The Ottawa Hospital.
Dr. Keigan
More
Director: Atlantic Provinces
(2026 – 2029)
Dr. Keigan More
Director: Atlantic Provinces (2026 – 2029)
Dr. Keigan More is a Nephrologist and Assistant Professor of Medicine at Dalhousie University in Halifax, Nova Scotia. He received his MD at the University of British Columbia and completed Internal Medicine and Nephrology training at Dalhousie University. He also completed a Master of Science in Quality Improvement and Patient Safety at the Institute of Health Policy, Management and Evaluation at the University of Toronto. Currently, he is serving as Program Director for the Adult Nephrology Royal College training program at Dalhousie University and is the Medical Director of Renal Quality for the Nova Scotia Renal Program, Central Zone. He is also a member of the CSN Quality Improvement & Implementation Science (QUIS) Committee.
Dr. Samuel
Silver
Chair: QUIS Committee
(2024 – 2027)
Dr. Samuel Silver
Chair: Quality Improvement & Implementation Science Committee (2024 – 2027)
Samuel Silver is an Associate Professor in the Division of Nephrology at Queen’s University in Kingston, Ontario, Canada. He completed his clinical training in internal medicine and nephrology at the University of Toronto. He holds a Master of Science in quality improvement and patient safety and completed the Veteran Affairs Quality Scholars program at the University of California-San Francisco. Samuel then trained as a research fellow at Stanford University, with a focus on health services research. Samuel has received salary support through the Kidney Research Scientist Core Education and National Training (KRESCENT) program, as well as funding from CIHR, the Kidney Foundation of Canada, and Ontario Renal Network. The objective of his research program is to use administrative data and systematic reviews to inform the design of quality improvement interventions that may improve patient outcomes, with a focus on patients with acute kidney injury and patients receiving in-centre hemodialysis.
Dr. Caroline
Stigant
Chair: Sustainable Nephrology Action Planning Committee (SNAP)
(2024 – 2027)
Dr. Caroline Stigant
Chair: Sustainable Nephrology Action Planning Committee (2024 – 2027)
Dr. Stigant is a mother, gardener, educator, and climate activist via the development and practice of environmentally sustainable kidney care. She completed her nephrology training at the University of Toronto then obtained a Master of Health Science degree in CKD epidemiologic research as recipient of a Kidney Foundation of Canada biomedical fellowship. She conceived and delivers the undergraduate UBC medicine lecture “The climate crisis, planetary health, and medical practice - a call to action”. She is an associate professor of medicine at UBC, and co-investigator and inaugural lead of kidney research at UBC's Planetary Healthcare Lab, studying the environmental impact of kidney therapies. Dr. Stigant serves as chair of the Sustainable Nephrology Action Planning 'SNAP' Committee of the Canadian Society of Nephrology. She is inaugural medical lead of BC Renal's innovative Planetary Health initiative, and a collaborator with CASCADES Canada in the development of sustainable kidney care resources funded by Environment and Climate Change Canada. Dr. Stigant is proud to represent the CSN in the 'GREEN-K' (Global Environmental Evolution in Nephrology and Kidney Care) initiative of the ISN, currently serving as committee vice chair, as well as lead of its Procurement, Infrastructure, and Innovation workstream. An enduring vision is the alignment of medical practice with planetary health principles.
Dr. Michael
Walsh
Chair: Scientific Committee
(2024 – 2027)
Dr. Michael Walsh
Chair: Scientific Committee (2024 – 2027)
Dr. Walsh obtained his MD in 2001, completed internal medicine in 2005, Nephrology training in 2006 and a MSc in Community Health Science in 2008 all at the University of Calgary. He then trained in lupus and vasculitis in Cambridge, UK as KRESCENT fellow until 2009, followed by a PhD in Health Research Methods at McMaster University until 2014 under a RCT Mentorship Award from CIHR. He is now an Associate Professor of Medicine (Nephrology) and Health Research Methods, Evidence & Impact at McMaster University, medical director of the Glomerulonephritis Clinic and the director of the Clinical Nephrology Research Group at St. Joseph’s Healthcare, and Scientist at the Population Health Research Institute where he leads research investigating treatments for patients with kidney diseases with particular interests in glomerular diseases, vasculitis, symptoms of kidney failure, and cardiovascular complications of kidney diseases.
